Tenderwize
Back to tender search

Open-House Biologics Discount Agreements 2026-05 - Pegfilgrastim

Techniker Krankenkasse·Hamburg, Germany·Deadline Apr 29, 2028 · 620 days left·Open·Supplies
Sign up to saveOpen documents
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2026-05 - Pegfilgrastim

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

50 / 100

Complexity

20 / 100

Risk factors

No estimated contract value or framework maximum value is disclosed. Potential revenue is unknown.

The procedure is not a public procurement under EU directives; legal recourse is via social courts, not procurement tri...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Apr 2028
  • Supply of Pegfilgrastim pharmaceutical products under discount agreements.
  • Nationwide coverage in Germany.
Show full summary

Open-House procedure for pharmaceutical discount agreements (Rabattverträge) for the active substance Pegfilgrastim, conducted by Techniker Krankenkasse (lead buyer) together with HEK and hkk. The procedure is open to all eligible pharmaceutical entrepreneurs at any time during the contract period. No estimated value, no award criteria, and no procurement documents were analyzed. The contract duration is 24 months from May 2026 to April 2028.

Risks

No estimated contract value or framework maximum value is disclosed. Potential revenue is unknown.

The procedure is not a public procurement under EU directives; legal recourse is via social courts, not procurement tri...

Key Requirements

Technical

  • Must be a pharmaceutical entrepreneur according to § 4 Abs. 18 AMG for the offered medicines.
  • Must have a valid marketing authorization for the medicine(s) in Germany or equivalent.

Administrative

  • Must submit a self-declaration on authorization and company (Anlage 4 zum Vertrag).

Requirements may be incomplete.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open-House Biologics Discount Agreements 2026-05 - Pegfilgrastim

Conclusion of pharmaceutical discount agreements according to § 130a Abs. 8 SGB V for Pegfilgrastim via an open-house procedure. All eligible pharmaceutical entrepreneurs can join at any time during the contract period. No exclusivity is granted.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Apr 2026 - Apr 2028

Category

Pharmaceutical products

Deadline

Deadline Apr 29, 2028

Procurement Details

Publication date
18 Mar 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
190019-2026

Documents (1)

Procurement document 1

Similar tenders

Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)

Sep 15
1 SME lot

Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów

Sep 17

France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord

Sep 14
6 SME lots

Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)

Aug 27
3 framework lots3 SME lots

Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ

Sep 18

Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).

Sep 24